Where Does Compugen Ltd. (CGEN) Stock Fall in the Biotechnology Field? – InvestorsObserver

Compugen Ltd. (CGEN) is around the top of the Biotechnology industry according to InvestorsObserver. CGEN received an overall rating of 69, which means that it scores higher than 69 percent of all stocks. Compugen Ltd. also achieved a score of 83 in the Biotechnology industry, putting it above 83 percent of Biotechnology stocks. Biotechnology is ranked 20 out of the 148 industries.

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. Investors Observer makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.

Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObservers overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. Theres no need to try to remember what is good for a bunch of complicated ratios, just pay attention to which numbers are the highest.

Compugen Ltd. (CGEN) stock is trading at $19.36 as of 11:39 AM on Wednesday, Aug 19, an increase of $1.55, or 8.7% from the previous closing price of $17.81. The stock has traded between $17.83 and $19.46 so far today. Volume today is 1,171,509 compared to average volume of 1,311,529.

To see InvestorsObserver's Sentiment Score for Compugen Ltd. click here.

Originally posted here:
Where Does Compugen Ltd. (CGEN) Stock Fall in the Biotechnology Field? - InvestorsObserver